Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on MedeFile International, Inc.

NEW YORK, NY--(Marketwire - Jun 29, 2011) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview^® (EIO^®) on MedeFile International, Inc. (OTCQB: MDFI) (PINKSHEETS: MDFI). The full 52-page report can be found at www.crystalra.com.

MedeFile International, Inc. ("MedeFile" or "the Company") is a healthcare information technology (IT) company that develops and markets its branded product, called MedeFile, which is a proprietary web-based system for storing personal health records (PHRs). MedeFile is a full-service solution that collects members' actual medical records from a variety of sources and then organizes and electronically stores these documents in a secure, central location. Members can access information, anywhere and at any time, through multiple channels, including via a secure Internet portal and/or web-enabled mobile device, as well as through the Company's patent-pending MedeDrive™, which is a specially designed Universal Serial Bus (USB) drive.

MedeFile's flexible design allows subscribers to tailor the system to their needs -- selecting what information is collected and from where, and defining rules for sharing that information with third parties, such as physicians, pharmacists, family members, or caretakers. The MedeFile solution also entails additional services, such as an interactive health calendar, a reminder service for medications and appointments, and a drug-to-drug interaction module. The Company believes that MedeFile's multiple access points, unlimited storage space, automatically updated records, portability, and privacy features provide a competitive advantage in the marketplace.

Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us on Twitter at http://twitter.com/crystalresearch or visit http://crystalra.com/blog/ for industry and company news for clients under our research coverage.

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality research on small- and mid-cap companies. The firm is led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street and for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked on Wall Street among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks. Additionally, Mr. Kraws has been 5-Star Ranked for top biotechnology stock performance by Starmine.

Crystal Research Associates' unique and novel product, the Executive Informational Overview^® (EIO^®), is free of investment ratings, target prices, and forward-looking financial models. The EIO^® presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO^® details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, West Palm Beach, Montréal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty eight thousand five hundred dollars and ten million warrants for its services in creating the base report, for quarterly updates, and for printing costs.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.